SARS-CoV-2 Nucleocapsid antibody
Quick Overview for SARS-CoV-2 Nucleocapsid antibody (ABIN6990049)
Target
See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- Greater than 95% as determined by reducing SDS-PAGE.
-
Immunogen
- Nucleocapsid recombinant protein
-
-
-
-
Application Notes
- ELISA: 1:160000, WB: 1:2000~3000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 10 % glycerol, pH 7.2
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,4 °C
-
Storage Comment
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Alternative Name
- SARS-CoV-2 Nucleocapsid
-
Target Type
- Viral Protein
-
Background
- Fully humanized monoclonal antibody paired with human monoclonal antibody LOCUS:QHD43423 419aa linear VRL 18-MAR-2020 DEFINITION:nucleocapsid phosphoprotein [Severe acute respiratory syndrome coronavirus 2]. ACCESSION:QHD43423 VERSION:QHD43423.2 DBSOURCE:accession MN908947.3 SOURCE:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ORGANISM:Viruses, Riboviria, Nidovirales, Cornidovirineae, Coronaviridae,Orthocoronavirinae, Betacoronavirus, Sarbecovirus.
-
Gene ID
- 43740575
Target
-